Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. SPY
5. NVDA
6. AVGO
7. SPCX
8. DE
9. OSIS
10. REAX

Go back to Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial
iShares Diversified Alternatives Trust (NASDAQ: ALT) Delayed: 3.11 +0.16 (5.42%)
Previous Close $2.95    52 Week High $54.24 
Open $2.98    52 Week Low $48.35 
Day High $3.24    P/E N/A 
Day Low $2.95    EPS $0.00 
Volume 6,157,316